CompletedNot Applicable

MRI Study of Cerebral Blood Flow in Development Disorders in Children

France115 participantsStarted 2013-11-13

Plain-language summary

The purpose of this study is reproduce the individual detection results by PET with Arterial Spin Labeling (ASL) MRI, to establish a biomarker useful in autism diagnosis.

Who can participate

Age range18 Months – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 18 months ≤ age \<5 years
✓. demand of MRI in the etiologic assessment
✓. obtaining written consent from parents or legal guardians.
✓. 18 months ≤ age \<5 years
✓. demand of MRI in the etiologic assessment
✓. obtaining written consent from parents or legal guardians.

What they're measuring

CBF

Timeframe: at day 0

Trial details

NCT IDNCT02165410

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-13

View on ClinicalTrials.gov More Autism trials